Search Results - "Hajarizadeh, B"

Uptake of direct‐acting antiviral treatment for chronic hepatitis C in Australia by Hajarizadeh, B., Grebely, J., Matthews, G. V., Martinello, M., Dore, G. J.

“…Summary A government‐funded interferon‐free direct‐acting antiviral (DAA) treatment programme for chronic hepatitis C virus (HCV) infection has been available…”
Get full text

Prevalence of hepatitis C virus exposure and infection among Indigenous and tribal populations: a global systematic review and meta-analysis by Elliott, S., Flynn, E., Mathew, S., Hajarizadeh, B., Martinello, M., Wand, H., Ward, J.

“…The objective of this study was to estimate prevalence of hepatitis C virus (HCV) exposure and infection among Indigenous and tribal populations globally…”
Get full text

Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005‐2014: The HITS‐p study by Cunningham, E. B., Hajarizadeh, B., Bretana, N. A., Amin, J., Betz‐Stablein, B., Dore, G. J., Luciani, F., Teutsch, S., Dolan, K., Lloyd, A. R., Grebely, J., Haber, Paul, Rawlinson, William, Treloar, Carla, Maher, Lisa

“…Summary Hepatitis C virus (HCV) transmission is high in prisons. This study investigated trends in HCV incidence and associated factors among a cohort of…”
Get full text

More than a virus: a qualitative study of the social implications of hepatitis B infection in China by Wallace, J, Pitts, M, Liu, C, Lin, V, Hajarizadeh, B, Richmond, J, Locarnini, S

“…China has the largest absolute number of people living with hepatitis B with up to 300,000 people estimated to die each year from hepatitis B related diseases…”
Get full text

Higher incidence of HCV in females compared to males who inject drugs: A systematic review and meta‐analysis by Esmaeili, A., Mirzazadeh, A., Carter, G. M., Esmaeili, A., Hajarizadeh, B., Sacks, H. S., Page, K. A.

“…Women who inject drugs have been shown to have higher incidence of HIV and risk behaviours than men, but there are conflicting reports about hepatitis C virus…”
Get full text

The path towards hepatitis C elimination in Australia following universal access to interferon-free treatments by Hajarizadeh, B, Grebely, J, Matthews, G.V, Martinello, M, Dore, G.J

Get full text

Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C: An international study by Alavi, M., Janjua, N. Z., Chong, M., Grebely, J., Aspinall, E. J., Innes, H., Valerio, H., Hajarizadeh, B., Hayes, P. C., Krajden, M., Amin, J., Law, M. G., George, J., Goldberg, D. J., Hutchinson, S. J., Dore, G. J.

“…Summary This study evaluates trends in hepatitis C virus (HCV)‐related hepatocellular carcinoma (HCC) incidence and survival in three settings, prior to…”
Get full text

Injecting risk behaviours among people with a history of injecting drug use in an Australian prison setting, 2005–2014: the HITS-p study by Cunningham, E.B, Hajarizadeh, B, Amin, J, Bretana, N.A, Luciani, F, Degenhardt, L, Larney, S, Dore, G.J, Lloyd, A.R, Grebely, J

Get full text

No evidence for higher risk of hepatocellular carcinoma occurrence or recurrence following direct-acting antiviral HCV therapy: a systematic review, meta-analyses, and meta-regression by Waziry, R, Hajarizadeh, B, Grebely, J, Amin, J, Law, M, Danta, M, George, J, Dore, G.J

Get full text

Letter: the rs12979860 and ss469415590 polymorphisms of IFNL4 gene are in strong linkage disequilibrium in Caucasian patients with chronic hepatitis C by Keshvari, M., Pouryasin, A., Behnava, B., Sharafi, H., Hajarizadeh, B., Alavian, S. M.

Get full text

Stable Incidence of Hepatitis C Virus Infection among People with a History of Injecting Drug Use in an Australian Prison Setting, 2005–2014: The Hits-P Study by Cunningham, E.B, Luciani, F, Hajarizadeh, B, Betz-Stablein, B, Bretana, N.A, Teutsch, S, Dore, G.J, Grebely, J, Lloyd, A.R

Get full text

Hepatitis C virus core antigen and dried blood spots as simplified hepatitis C virus diagnostic tools by Lamoury, F.M, Hajarizadeh, B, Soker, A, Martinez, D, Quek, C, Cunningham, P, Catlett, B, Cloherty, G.A, Marks, P, Amin, J, Grebely, J, Dore, G.J, Applegate, T.L

Get full text

A framework for hepatitis C virus treatment as prevention in the prison setting: the SToP-C implementation toolkit by Byrne, M, Hajarizadeh, B, Dore, G.J, Treloar, C, Marks, P, Milat, A, Bowman, J, McGrath, C, Bath, N, Calder, I, Lagios, K, Grebely, J, Lloyd, A

Get full text

Incidence of hepatitis C virus infection in two maximum-security prisons in New South Wales, Australia: the SToP-C study by Hajarizadeh, B, Grebely, J, Byrne, M, Marks, P, Amin, J, Butler, T, Vickerman, P, Martin, N.K, Mchutchison, J.G, Brainard, D.M, Treloar, C, Lloyd, A.R, Dore, G.J

Get full text

Field evaluation of Xpert® HCV Viral Load point-of-care test for detection of hepatitis C virus infection by venipuncture-collected and finger-stick capillary whole-blood samples by Grebely, J, Lamoury, F, Hajarizadeh, B, Mowat, Y, Marshall, A, Bajis, S, Marks, P, Amin, J, Smith, J, Edwards, M, Gorton, C, Ezard, N, Persing, D, Kleman, M, Cunningham, P, Catlett, B, Dore, G, Applegate, T.L

Get full text

Hepatitis C Virus Core Antigen: A Simplified Treatment Monitoring Tool, including for Post-Treatment Relapse by Lamoury, F, Soker, A, Martinez, D, Hajarizadeh, B, Cunningham, E, Bruggmann, P, Foster, G, Dalgard, O, Conway, B, Robaeys, G, Swan, T, Backmund, M, Marks, P, Grebely, J, Dore, G.J, Applegate, T.L

Get full text

Efficacy and safety of sofosbuvir/velpatasvir in people with chronic hepatitis C virus infection and recent injecting drug use: the SIMPLIFY study by Grebely, J, Dalgard, O, Conway, B, Cunningham, E, Bruggmann, P, Hajarizadeh, B, Amin, J, Marks, P, Quiene, S, Applegate, T.L, Swan, T, Byrne, J, Lacalamita, M, Dunlop, A.J, Bruneau, J, Hellard, M.E, Matthews, G.V, Powis, J, Shaw, D, Thurnheer, C.M, Weltman, M, Kronborg, I, Cooper, C, Feld, J.J, Fraser, C, Litwin, A, Dillon, J, Read, P, Gane, E, Dore, G.J

Get full text

Factors associated with hepatitis C virus RNA levels in early chronic infection: the InC3 study by Hajarizadeh, B., Grady, B., Page, K., Kim, A. Y., McGovern, B. H., Cox, A. L., Rice, T. M., Sacks-Davis, R., Bruneau, J., Morris, M., Amin, J., Schinkel, J., Applegate, T., Maher, L., Hellard, M., Lloyd, A. R., Prins, M., Geskus, R. B., Dore, G. J., Grebely, J.

“…Summary Improved understanding of natural history of hepatitis C virus (HCV) RNA levels in chronic infection provides enhanced insights into immunopathogenesis…”
Get full text

P20 Monitoring the uptake of hepatitis C: direct acting antiviral treatment in Australia by B. Hajarizadeh, J. Grebely, G.V. Matthews, M. Martinello, G.J. Dore

Get full text

P0848 : Efficacy of response-guided pegylated interferon and ribavirin therapy for people who inject drugs with HCV genotype 2/3 infection: The activate study by Grebely, J, Dalgard, O, Conway, B, Foster, G, Bruggmann, P, Backmund, M, Robaeys, G, Swan, T, Hajarizadeh, B, Amin, J, Marks, P, Quiene, S, Weltman, M, Shaw, D, Dunlop, A, Hellard, M, Bruneau, J, Bourgeois, S, Thurnheer, C, Dore, G.J

Get full text